177 related articles for article (PubMed ID: 25754108)
41. The vicious cycle of inadequate early detection: a complementary study on barriers to cervical cancer screening among middle-aged and older women.
Leach CR; Schoenberg NE
Prev Chronic Dis; 2007 Oct; 4(4):A95. PubMed ID: 17875270
[TBL] [Abstract][Full Text] [Related]
42. COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.
DeGroff A; Miller J; Sharma K; Sun J; Helsel W; Kammerer W; Rockwell T; Sheu A; Melillo S; Uhd J; Kenney K; Wong F; Saraiya M; Richardson LC
Prev Med; 2021 Oct; 151():106559. PubMed ID: 34217410
[TBL] [Abstract][Full Text] [Related]
43. Preliminary results of the first cervical cancer screening programme in the North Eastern region of Romania.
Păvăleanu I; Gafiţanu D; Ioanid N; Grigore M
J Med Screen; 2018 Sep; 25(3):162-165. PubMed ID: 29764329
[TBL] [Abstract][Full Text] [Related]
44. Assessing Cervical Cancer Screening Coverage Using a Population-Based Behavioral Risk Factor Survey--Thailand, 2010.
Joseph R; Manosoontorn S; Petcharoen N; Sangrajrang S; Senkomago V; Saraiya M
J Womens Health (Larchmt); 2015 Dec; 24(12):966-8. PubMed ID: 26653868
[TBL] [Abstract][Full Text] [Related]
45. Adapting the Australian system: is an organized screening program feasible in Malaysia?--an overview of cervical cancer screening in both countries.
Rashid RM; Dahlui M; Mohamed M; Gertig D
Asian Pac J Cancer Prev; 2013; 14(3):2141-6. PubMed ID: 23679334
[TBL] [Abstract][Full Text] [Related]
46. From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program.
Miller JW; Hanson V; Johnson GD; Royalty JE; Richardson LC
Cancer; 2014 Aug; 120 Suppl 16(0 16):2549-56. PubMed ID: 25099897
[TBL] [Abstract][Full Text] [Related]
47. Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
Coldman A; van Niekerk D; Smith L; Ogilvie G
J Med Screen; 2017 Dec; 24(4):195-200. PubMed ID: 27810984
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of the National Cervical Cancer Screening Programme in Singapore.
Jin AZ; Louange EC; Chow KY; Fock CW
Singapore Med J; 2013 Feb; 54(2):96-101. PubMed ID: 23462834
[TBL] [Abstract][Full Text] [Related]
49. Impact of ASC-H terminology on the detection of HSILs in medically underserved California women.
Howell LP; Gurusinghe S; Tabnak F
Diagn Cytopathol; 2009 Feb; 37(2):103-10. PubMed ID: 19021201
[TBL] [Abstract][Full Text] [Related]
50. Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States).
Eheman CR; Benard VB; Blackman D; Lawson HW; Anderson C; Helsel W; Lee NC
Cancer Causes Control; 2006 Feb; 17(1):29-38. PubMed ID: 16411050
[TBL] [Abstract][Full Text] [Related]
51. Cervical cancer screening among women aged 18-30 years - United States, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Jan; 61(51-52):1038-42. PubMed ID: 23282861
[TBL] [Abstract][Full Text] [Related]
52. Factors associated with cervical cancer screening in Puerto Rico.
Ortiz AP; Hebl S; Serrano R; Fernandez ME; Suárez E; Tortolero-Luna G
Prev Chronic Dis; 2010 May; 7(3):A58. PubMed ID: 20394697
[TBL] [Abstract][Full Text] [Related]
53. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
54. Effectiveness of screening for cervical cancer in an inpatient hospital setting.
Trimble CL; Richards LA; Wilgus-Wegweiser B; Plowden K; Rosenthal DL; Klassen A
Obstet Gynecol; 2004 Feb; 103(2):310-6. PubMed ID: 14754701
[TBL] [Abstract][Full Text] [Related]
55. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
[TBL] [Abstract][Full Text] [Related]
56. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
57. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
58. Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program.
Bui CN; Hong S; Suh M; Jun JK; Jung KW; Lim MC; Choi KS
J Gynecol Oncol; 2021 Sep; 32(5):e81. PubMed ID: 34378364
[TBL] [Abstract][Full Text] [Related]
59. Cervical cancer screening with AMIGAS: a cost-effectiveness analysis.
Lairson DR; Chang YC; Byrd TL; Lee Smith J; Fernandez ME; Wilson KM
Am J Prev Med; 2014 Jun; 46(6):617-23. PubMed ID: 24842738
[TBL] [Abstract][Full Text] [Related]
60. Carcinoma of the cervix in Southwestern American indians: results of a cytologic detection program.
Jordan SW; Key CR
Cancer; 1981 May; 47(10):2523-32. PubMed ID: 7272903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
